Learn what it's like to receive funding from the Foundation and partner on our mission to ensure the development of new and better treatments for people living with Parkinson's disease today.
FAQs: Coronavirus (COVID-19) & Research Support
We understand that the circumstances surrounding COVID-19 may be impacting your organization. Please review our FAQs for guidance.
The Michael J. Fox Foundation works tirelessly to accelerate promising research toward breakthroughs for people with Parkinson's. Our funding programs support basic, translational and clinical research from academia and industry. In addition to funding, awardees benefit from working with our internal research staff and broad network of scientific and industry advisors.
Webinars for Researchers
Our research webinars include regular sessions on our funding opportunities and a series on hot topics in Parkinson's research and development. Register for upcoming webinars or watch previous sessions on demand.
Our funding application guidelines cover our review process and criteria, confidentiality, conflicts of interest and special requirements to help potential grantees submit appropriate and compelling funding applications.
Parkinson's Disease Therapeutics Conference
The Parkinson's Disease Therapeutics Conference is The Michael J. Fox Foundation's annual scientific conference and the only one in the world focused exclusively on Parkinson's disease drug development.
View a list of leading experts around the world who dedicate their time and insight to help the Foundation shape our research strategy. Register to be a Fox Advisor to help review grant applications and track progress.
Meetings and Consortia
Our Foundation frequently organizes consortia of grantees and other experts working in similar areas to share methods and findings, identify challenges to progress, and propose resources and initiatives to overcome those hurdles. Foundation consortia are focused around various topics, such as priority targets (e.g., parkin or GBA) and resources (e.g., pre-clinical tools, patient education). Our consortia are open to open to academia, industry groups and CROs and facilitates resource and data sharing through discussions and collaborations. Email us at firstname.lastname@example.org to learn more.